Format

Send to

Choose Destination
Bone Marrow Transplant. 2019 Nov 19. doi: 10.1038/s41409-019-0747-2. [Epub ahead of print]

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT).

Author information

1
School of Health and Related Research, University of Sheffield, Sheffield, UK. p.tappenden@sheffield.ac.uk.
2
School of Health and Related Research, University of Sheffield, Sheffield, UK.
3
Academic Department of Neuroscience, Sheffield INHR BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
4
Department of Neuroscience, Uppsala University, Uppsala, Sweden.
5
Kings Health Partners, Department of Haematology, Guys Hospital, London, UK.
6
Haematology Department, Careggi University Hospital, Florence, Italy.
7
Cabourn Statistics Ltd, Manchester, UK.
8
EBMT Paris study office / CEREST-TC-Department of Haematology, Saint Antoine Hospital-INSERM UMR 938-Université Pierre et Marie Curie, Paris, France.
9
Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Autoimmune and Vascular Disease Unit, Internal Medicine (UF04), Center of Reference for Rare Systemic Autoimmune Diseases (FAI2R), Université de Paris, EA 3518, Paris, France.
10
Department of Medicine, McGill University, Montreal, QC, Canada.
11
Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
PMID:
31745252
DOI:
10.1038/s41409-019-0747-2

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center